LUMOS PHARMA INC's ticker is LUMO and the CUSIP is 55028X109.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,544,879 | 0.0% | 468,145 | 0.0% | 0.01% | -14.3% |
| Q2 2023 | $1,544,879 | -0.3% | 468,145 | 0.0% | 0.01% | +16.7% |
| Q1 2023 | $1,549,560 | -8.3% | 468,145 | 0.0% | 0.01% | 0.0% |
| Q4 2022 | $1,690,003 | +40691.8% | 468,145 | 0.0% | 0.01% | -60.0% |
| Q3 2022 | $4,143 | -99.9% | 468,145 | 0.0% | 0.02% | +25.0% |
| Q2 2022 | $3,605,000 | -18.1% | 468,145 | 0.0% | 0.01% | +9.1% |
| Q1 2022 | $4,401,000 | +35.7% | 468,145 | 0.0% | 0.01% | +37.5% |
| Q4 2021 | $3,244,000 | -27.1% | 468,145 | 0.0% | 0.01% | -20.0% |
| Q3 2021 | $4,452,000 | -4.9% | 468,145 | 0.0% | 0.01% | -9.1% |
| Q2 2021 | $4,681,000 | -14.5% | 468,145 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $5,477,000 | -67.2% | 468,145 | 0.0% | 0.01% | -81.4% |
| Q4 2020 | $16,717,000 | +158.4% | 468,145 | 0.0% | 0.06% | +136.0% |
| Q3 2020 | $6,470,000 | -16.2% | 468,145 | 0.0% | 0.02% | -24.2% |
| Q2 2020 | $7,720,000 | +94.0% | 468,145 | 0.0% | 0.03% | +13.8% |
| Q1 2020 | $3,979,000 | – | 468,145 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lion Point Capital, LP | 407,192 | $5,627,000 | 1.23% |
| Opaleye Management Inc. | 240,892 | $3,329,000 | 0.65% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 936,291 | $12,940,000 | 0.32% |
| NEA Management Company, LLC | 526,663 | $7,278,000 | 0.31% |
| Investors Financial Group, LLC | 21,766 | $301,000 | 0.22% |
| Wealth Advisors of Iowa, LLC | 11,760 | $163,000 | 0.11% |
| Blackstone Inc. | 468,145 | $6,470,000 | 0.02% |
| Jefferies Group LLC | 120,651 | $1,667,000 | 0.02% |
| Texas Yale Capital Corp. | 16,000 | $221,000 | 0.02% |
| Prospera Financial Services Inc | 1,088 | $15,000 | 0.01% |